,,ib ,union ,calendar ,no4 #fad #aaith ,,congress #b;d ,session ,h4 ,r4 #bhba ,report ,no4 #aai-gjf ,,in ,,the ,,house ,,of ,,representatives ,april #aj1 #bjbe,mr4 ,carter of ,georgia 7for himself1 ,ms4 ,barragn1 ,mr4 ,buchanan1 ,ms4 ,de,lauro1 ,mrs4 ,harshbarger1 and ,mr4 ,carter of ,louisiana7 introduced the following bill2 which was referred to the ,committee on ,energy and ,commerce ,june #ah1 #bjbf;,additional sponsors3 ,mr4 ,doggett1 ,mr4 ,nadler1 ,mr4 ,carey1 ,mr4 ,fitzpatrick1 ,ms4 ,malliotakis1 ,mr4 ,crenshaw1 ,ms4 ,chu1 ,ms4 ,scholten1 ,mr4 ,soto1 ,mr4 ,goldman of ,new ,york1 ,mr4 ,obernolte1 ,mr4 ,gottheimer1 ,mr4 ,crow1 ,mr4 ,lieu1 ,ms4 ,tenney1 ,mr4 ,smith of ,new ,jersey1 ,ms4 ,norton1 ,ms4 ,salazar1 ,ms4 ,lois ,frankel of ,florida1 ,mr4 ,valadao1 ,mr4 ,harder of ,california1 ,mr4 ,fitzgerald1 ,mr4 ,bilirakis1 ,ms4 ,lee of ,florida1 ,mr4 ,calvert1 ,mr4 ,vindman1 ,mr4 ,pocan1 ,mr4 ,lawler1 ,mr4 ,weber of ,texas1 ,mr4 ,neguse1 ,mr4 ,krishnamoorthi1 ,mr4 ,kean1 ,ms4 ,johnson of ,texas1 ,mrs4 ,kim1 ,mr4 ,langworthy1 and ,mr4 ,thanedar ,june #ah1 #bjbf;,committed to the ,committee of the ,whole ,house on the ,state of the ,union and ordered to be printed ,a ,,bill ,to require the ,secretary of ,health and ,human ,services1 acting through the ,commissioner of ,food and ,drugs1 to publish a final rule relating to nonclinical testing methods4 #a4 ,short title ,this ,act may be cited as the ,,fda ,modernization ,act #c4j4 #b4 ,regulations on nonclinical testing methods 7a7 ,interim final rule 7#a7 ,in general ,in order to ensure implementation of the amendments to section #eje7;i7 of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cee7;i77 made by section #cbji7;a7 of the ,consolidated ,appropriations ,act1 #bjbc 7,public ,law #aag-cbh2 #acf ,stat4 #ehba71 not later than #a year after the date of enactment of this ,act1 the ,secretary of ,health and ,human ,services1 acting through the ,commissioner of ,food and ,drugs1 shall publish an interim final rule-- 7,a7 to amend the sections of title #ba1 ,code of ,federal ,regulations1 described in paragraph 7#b7 to replace any references to animal tests1 data1 studies1 models1 and research with a reference to nonclinical tests1 data1 studies1 models1 and research2 and 7,b7 to add the definition of nonclinical test in section #eje7z7 of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cee7z77 to sections #cab4c1 #cad4c1 #cae4b1 and #fja4ca of title #ba1 ,code of ,federal ,regulations4 7#b7 ,,cfr sections described ,the sections of title #ba1 ,code of ,federal ,regulations1 described in this paragraph are the following3 7,a7 ,section #cab4bb7;c74 7,b7 ,section #cab4bc7;a77#c77;iv74 7,c7 ,section #cab4bc7;a77#e77;ii74 7,d7 ,section #cab4bc7;a77#e77;iii74 7,e7 ,section #cab4bc7;a77#h74 7,f7 ,section #cab4bc7;a77#h77;i74 7,g7 ,section #cab4bc7;a77#h77;ii74 7,h7 ,section #cab4bc7;a77#aj77;i74 7,i7 ,section #cab4bc7;a77#aj77;ii74 7,j7 ,section #cab4cc7;b77#f74 7,k7 ,section #cab4hb7;a74 7,l7 ,section #cab4hh4 7,m7 ,section #cad4ej7;d77#b74 7,n7 ,section #cad4ej7;d77#b77;iv74 7,o7 ,section #cad4ej7;d77#e77;i74 7,p7 ,section #cad4ej7;d77#e77vi77a74 7,q7 ,section #cad4ej7;d77#e77vi77b74 7,r7 ,section #cad4ic7;e77#b74 7,s7 ,section #cae4f7;d74 7,t7 ,section #ccj4aj7;a77#b74 7,u7 ,section #fja4ce7;d74 7,v7 ,any other section necessary to ensure regulatory consistency with the amendments to section #eje7;i7 of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cee7;i77 made by section #cbji7;a7 of the ,consolidated ,appropriations ,act1 #bjbc 7,public ,law #aag-cbh2 #acf ,stat4 #ehba74 7#c7 ,effectiveness of interim final rule ,notwithstanding subparagraph 7,b7 of section #eec7;b7 of title #e1 ,united ,states ,code1 the interim final rule issued by the ,secretary of ,health and ,human ,services under paragraph 7#a7 shall become immediately effective as an interim final rule without requiring the ,secretary of ,health and ,human ,services to demonstrate good cause therefor4 7b7 ,technical amendment ,section #eje of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cee7 is amended by designating the second subsection 7z7 7relating to clinical trial diversity action plans71 as added by section #cfja7;a7 of the ,health ,extenders1 ,improving ,access to ,medicare1 ,medicaid1 and ,,chip1 and ,strengthening ,public ,health ,act of #bjbb 7division ,,ff of ,public ,law #aag-cbh71 as subsection 7aa74 ,june #ah1 #bjbf;,committed to the ,committee of the ,whole ,house on the ,state of the ,union and ordered to be printed